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A total of 83% of men state that they use
deodorants on most days or daily com-
pared with a significantly higher proportion
(93%) of women who report daily usage.
Conversely, 4.7% of women with a geneti-
cally determined tendency to produce
body odor use deodorant less than once
a week compared with 13% of ‘‘genotypi-
cally odorous’’ men. The study authors did
not find statistical evidence of assortative
mating based on rs17822931 genotype.
Implications for pharmacogenomics
Although the study of body odor may
perhaps be viewed as a relatively trivial
concern, the sale of deodorants and anti-
perspirants represents an annual market
share of over $1.9 billion in the United
States (http://www.marketresearch.com/
map/prod/1209574.html) and appro-
ximately d548 million in the United
Kingdom, where an estimated 94% of
women and 87% of men are said to use
these products regularly (http://store.
mintel.com/deodorants-and-bodysprays-uk-
february-2011). The finding by Rodriguez
et al. that a proportion of individuals use
deodorant unnecessarily implies that the
market could be reduced, with possible
economic effects and environmental bene-
fits. However, among white Europeans, this
‘‘unnecessary’’ use of deodorant relates to
only about 1.2% of the population (i.e.,
78% of the 1.6% AA homozygous ‘‘geno-
typically nonodorous’’ individuals). There-
fore, it is not likely to have a large impact
on the deodorant/antiperspirant market.
This study illustrates an unusually sim-
ple example of pharmacogenetics.
Rodriguez et al. (2013) were careful to
compare additive and recessive models
of effect for ABCC11 genotype on deo-
dorant use. The additive model assumes
a step-wise change in phenotype when
comparing genotypes GG- GA- AA,
whereas a recessive model assumes that
the phenotype for genotypes GG and GA
are the same, but different from the
phenotype of AA. The results of associa-
tion analyses were generally similar
using additive and recessive models,
but there was some evidence of a hetero-
zygote effect, consistent with a gene-
tically determined dose effect of axillary
odorant production.
The genotype–phenotype association
between ABCC11 and body odor follows
a Mendelian pattern of inheritance, but
this is unlikely to be the case for the
majority of pharmacogenomic interac-
tions of clinical relevance (Crews et al.,
2012). It is predicted that multiple single-
nucleotide variants, as well as copy
number variations and epigenetic modifi-
cations affecting multiple genes and path-
ways, are likely to form more complex
interactions in the majority of derma-
tological conditions. While progress is
being made, the field of pharmaco-
genomics remains a significant challenge
to our understanding and its appli-
cation to patient care is an ongoing work.
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The Macrophage: A New Factor in
UVR-Induced Melanomagenesis
Tao Wang1 and Meenhard Herlyn1
UVR is one of the major risk factors for melanoma development. However, the
mechanisms by which UVR leads to the development of melanoma are not fully
understood. Handoko et al. (this issue) explicitly indicate that macrophages
are essential for UVR-induced melanocyte proliferation and migration using
a neonatal mouse model. Although the functions and mechanisms of
macrophages on melanoma development must be investigated further, the link
between macrophages and melanocyte responses is striking, suggesting that
macrophages might be a target for preventing UVR-induced melanoma.
Journal of Investigative Dermatology (2013) 133, 1711–1713. doi:10.1038/jid.2013.93
Epidemiological studies suggest that
there is a correlation between high
levels of UVR exposure, particularly
during childhood, and the risk of deve-
loping melanoma (Whiteman et al.,
2001; Gandini et al., 2005; Kanavy
and Gerstenblith, 2011). UVR exposure
induces DNA damage in human
melanocytes, causing mutations that
are associated with the development of
melanoma (Kanavy and Gerstenblith,
2011). Next-generation sequencing of
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melanoma genomes reveals that mela-
nomas in sun-exposed areas contain
a higher frequency of mutations than
those in nonexposed areas, and they
are characterized by a UV signature of
C to T or CC to TT transitions (Pleasance
et al., 2010; Berger et al., 2012; Hodis
et al., 2012; Krauthammer et al., 2012).
In addition to its direct effects on
melanocytes, UVR exposure also has
profound effects on other components
of the skin microenvironment, in parti-
cular, keratinocytes. UVR treatment
induces keratinocytes to produce cyto-
kines and growth factors that promote
melanocyte proliferation, migration, and
differentiation. UVR exposure also
elicits recruitment of inflammatory cells
because of an increase of skin blood
flow and release of inflammatory med-
iators, such as prostaglandin 2, IL-1, and
tumor necrosis factor-alpha (TNF-a),
among others (Halliday, 2005;
Garibyan and Fisher, 2010). Consistent
with this, it has been reported that the
long-term use of nonsteroidal anti-
inflammatory medications is associated
with a significantly decreased risk of
melanoma, potentially by amelioration
of cellular damage caused by UVR
(Curiel-Lewandrowski et al., 2011),
although these results must be further
confirmed (Jeter et al., 2011). Zaidi et al.
(2011) recently suggested that UVB
exposure significantly increases the
recruitment of macrophages to the skin,
which have critical roles in UVB-induced
melanomagenesis through the activation
of IFN-g-related signaling in melanocytes
of neonatal mice. In humans, UVR expo-
sure induces an increase in macrophages
in the skin, which may result in an
increase in melanocytes and contribute
to the immunosuppressive phenotype
(Kang et al., 1994). However, whether
and how macrophages contribute to
melanoma initiation and development
remains to be elucidated.
In this issue of Journal of Investigative
Dermatology, Handoko et al. (2013)
examine the roles and mechanisms
of macrophages in UVB-induced mela-
nocyte proliferation and migration using
a neonatal mouse model. They demon-
strate that a single dose of UVB on
neonatal mice results in an increase in
the number of melanocytes in the
epidermis, likely by promoting both
melanocyte proliferation and melano-
cyte migration from hair follicles to the
epidermis. The increase of melanocytes
is accompanied by a concurrent
increase in F4/80-positive macrophages
in the epidermal layer. Flow cytometric
analyses of these skin-infiltrating macro-
phages (SIMs) indicate a dynamic shift
of distinct subpopulations of macro-
phages. The authors found that the
percentage of Ly6chigh macrophages
increases in the epidermis at day 1 and
rapidly decreases at day 2 after UVB
exposure. The majority of macrophages
switch to Ly6clow ‘‘non-inflammatory’’
macrophages at day 2 after UVB
exposure, and this distribution is main-
tained for several days. Further charac-
terization indicated that around 60% of
Ly6clow ‘‘noninflammatory’’ macro-
phages are MHC IIhigh, and the increa-
sed percentage of this subpopulation of
macrophages is temporally correlated
with melanocyte responses. The data
suggest that Ly6clowMHChigh macro-
phages are the major subpopulation
that contributes to UVB-induced mela-
nocyte responses. More importantly, the
depletion of macrophages with clodro-
nate liposomes locally and systemically
reverses UVB-induced melanocyte res-
ponses. Systemic administration of
clodronate liposomes ablates the circu-
lating monocytes, but not the resident
macrophages, because the particles
cannot cross the endothelia of normal
capillary vessels (Van Rooijen and
Sanders, 1994), whereas local adminis-
tration can deplete resident skin and
newly recruited macrophages. There-
fore, the increased number of melano-
cytes in the skin after UVB treatment is
likely to be attributable to the increase
in macrophages recruited from the
blood stream to the skin.
To identify which genes confer UVB-
induced melanocyte responses, as well
as the increase in the number of macro-
phages, the investigators performed
gene expression microarray analyses to
compare gene expression profiles of
epidermis with and without UVB treat-
ment. They found that UVB upregulates
the expression of several immune-
related genes, including IL-33, MyD/88,
defensins, and TNF-a. However, none
of these molecules contributed to the
UVB-induced increase in melanocytes.
Interleukin-17, a cytokine that has pro-
found effects on both macrophages and
melanocytes (Shahrara et al., 2010), on
the other hand, confers UVB-induced
melanocyte responses. The investigators
observed a modest decrease in the
number of interfollicular epidermal
melanocytes in UVB-irradiated skin of
IL-17-knockout mice compared with
that of wild-type control mice. In
addition, after UVB exposure, IL-17-
knockout mice had fewer Ly6clowMHC
IIhigh macrophages than wild-type mice,
which further supports the notion that
Ly6clowMHCIIhigh macrophages might
confer the melanocyte responses




and migration in mice.
A surprising finding by Handoko et al.
(2013) is the lack of differences between
the number of macrophages and
melanocytes in IFN-g-knockout mice
compared with the number in wild-
type mice after neonatal exposure to
UVB, suggesting that IFN-g might not
directly affect UVB-induced melanocyte
responses. These findings seem to be at
odds with a previous study by Zaidi
et al. (2011) showing that macrophage-
derived IFN-g is indispensible for
melanogenesis in a UVB-irradiated neo-
natal mouse model. These discrepan-
cies, as the investigators indicate, may
be attributable to differences in post-
natal timing of UVB treatment, the time
between UVB exposure and melanocyte
counting, mouse strains, and the
methods used to block IFN-g signaling.
Nonetheless, given their complexity and
heterogeneity, it appears that the roles of
macrophages on UVB-induced melano-
cyte responses depend on multiple
factors, and not on one dominant
factor, such as IFN-g or IL-17.
More studies are warranted to dissect
the mechanisms of how the increased
number of macrophages affects melano-
cyte responses to UVB treatment. First, it
is not clear whether macrophages have
direct effects on melanocyte proliferation
and migration. If so, which signaling
pathways in melanocytes are activated
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by macrophages? Second, macrophage-
produced factors are also likely to acti-
vate keratinocytes or other cells in the
skin to release factors that promote
melanocyte proliferation and migration.
An in vitro co-culturing system, includ-
ing melanocytes, keratinocytes, and
macrophages, followed by in vivo vali-
dation, may identify signaling pathways
that are directly and/or indirectly acti-
vated by UVR exposure in melanocytes.
Third, even though IL-17 has a role in
the increase of melanocytes and macro-
phages on UVB exposure, the effect
appears modest, suggesting that other
factors also confer UVB-induced macro-
phage recruitment. Future studies
should be conducted to identify which
population of macrophages contributes
to UVB-induced melanocyte responses.
In Zaidi et al’s study (2011), it appears
that most SIMs are CCR2-positive
macrophages. However, CCR2-negative
Ly6clowMHChigh macrophages confer
melanocyte responses in Handoko
et al. (2013) study, even though both
groups have used CCR2-knockout mice
to address this question. Finally, it will
be interesting to determine whether
macrophages have a role in other skin
responses induced by UVB exposure.
For example, macrophages produce
many growth factors, extracellular
matrix (ECM) proteins, and cytokines
that might also critically affect immuno-
suppressive functions and differentiation
of melanocyte stem cells and progenitor
cells seen in UVB-treated mice.
Despite many challenges regarding
how macrophages contribute to UVB-
mediated melanoma development, both
Handoko et al. (2013) and Zaidi et al
provide strong evidence that macro-
phages are involved in the initiation of
melanoma; hence, targeting macro-
phages or their products might be used
as a novel approach to prevent mela-
noma development and progression.
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Do Not Underestimate Nucleotide
Excision Repair: It Predicts Not Only
Melanoma Risk but Also Survival
Outcome
Steffen Emmert1 and Kenneth H. Kraemer2
Nucleotide excision repair (NER) removes UV-induced DNA damage and other
bulky DNA lesions, thereby maintaining genomic integrity. Dr Qingyi Wei’s group
demonstrated over the last decade that NER fidelity and single-nucleotide
polymorphisms (SNPs) in NER genes constitute melanoma risk biomarkers. In
this issue, Li et al. provide evidence that SNPs in NER genes may also predict
melanoma survival.
Journal of Investigative Dermatology (2013) 133, 1713–1717. doi:10.1038/jid.2013.72
The melanoma problem
Skin cancer is the most frequent form
of cancer in Caucasians. Cutaneous
melanoma is the most aggressive form
of skin cancer and its frequency is
increasing rapidly. In the United States,
there were approximately 76,000 new
melanoma cases and 56,000 melanoma
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